[Only registered and activated users can see links. Click Here To Register...] However, in contrary to the NSABP B30 trial Swain et al, 2010, which suggested that both a longer course sequential regimen and a higher dose of docetaxel are important for maximum efficacy, our study showed that for node negative patients, less chemotherapy administered over a longer course is actually more beneficial
